Published by IQ4I on 30th May 2017 | Ref: 1005254 | This Report Is In Stock
In-vitro diagnostic is a process in which reagents, instruments, and systems are intended for the diagnosis of disease or other conditions or for determining the state of health, to cure, mitigate, treat, or prevent disease. This includes reagents, calibrators, control materials, specimen receptacles, software, and related instruments.
The in-vitro diagnostics market is segmented into Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Rapid tests, Enzyme-Linked Immunospot (Elispot) Assay and others are some of the immunoassay techniques in the IVD market. Basic Metabolic Panel, Electrolyte Panel, liver Panel, Lipid Profile, Renal Profile and Thyroid function panel and specialty chemical tests are some of the clinical chemistry technologies. Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), Microarray, Hybridization, DNA Sequencing & Next-Generation Sequencing and others are some of the molecular diagnostics market. Along with these, clinical microbiology, hematology, coagulation and hemostasis and others are the type of the IVD technologies in the market.
Among technologies in in-vitro diagnostics market, immunochemistry techniques accounted for the largest share in 2016 growing at mid range single digit CAGR and molecular diagnostics is expected to grow at high single digit CAGR from 2016-2023.
By application, the in-vitro diagnostics global market is segmented into oncology, diabetes, cardiology, nephrology, transplantation technology, genetic testing, autoimmune diseases, drug testing, infectious diseases and others. Infectious diseases held the largest revenue in 2016 and transplantation diagnostics application is expected to grow at double digit CAGR from 2016-2023.
By product type, the market is segmented into reagents, instruments, software and services. The reagents segment accounted for the largest revenue in 2016, and is expected to grow at mid range single digit CAGR from 2016 to 2023.
By sample type, the market is segmented into blood, urine, saliva and others. The blood segment accounted for the largest revenue in 2016, and is expected to grow at mid range single digit CAGR from 2016 to 2023.
By end-users, the market is segmented into laboratories, hospitals, academic, and home care. The hospitals end user segment accounted for the largest revenue in 2016, home healthcare is fastest growing segment during the forecasting period.
By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the in-vitro diagnosis market.
Growing healthcare expenditure in the emerging markets, strong demand for technologically advanced testing methods for disease diagnosis, increasing adaptation of point of care testing, increasing incidences of chronic lifestyle diseases are some of the important driving factors for this market. It is also seen that there is an increase in the number of clinical laboratories with improved infrastructure in many developed countries which could further push the diagnostics market in these regions. However, Lack of proper reimbursement policies in the developing countries and stringent regulatory framework are the main factors hampering the growth of the IVD market.
The in-vitro diagnostics global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the in-vitro diagnostics global market include Abbott Laboratories (U.S.), Becton Dickinson (U.S.), Bio-Rad laboratories (U.S.), BioMerieux (France), Danaher Corporation (U.S.), Hoffmann-la Roche (Switzerland), Siemens AG (Germany), Carlyle Group (Ortho Clinical Diagnostics) (U.S.), Johnson and Johnson (U.S.), Sysmex Corporation (Japan), ThermoFisher Scientific (U.S.), and Hologic Inc (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Rest of the World (RoW)
1 EXECUTIVE SUMMARY 36
2 INTRODUCTION 46
2.1 KEY TAKE AWAYS 46
2.2 REPORT DESCRIPTION 47
2.3 MARKETS COVERED 49
2.4 STAKEHOLDERS 52
2.5 RESEARCH METHODOLOGY 52
3 MARKET ANALYSIS 61
3.1 INTRODUCTION 61
3.2 MARKET SEGMENTATION 63
3.3 FACTORS INFLUENCING MARKET 65
3.4 PORTER’S FIVE FORCE ANALYSIS 75
3.5 REGULATORY AFFAIRS 80
3.6 TECHNOLOGICAL ADVANCEMENTS 85
3.7 FUNDING SCENARIO 87
3.8 SUPPLY CHAIN ANALYSIS 92
3.9 MARKET SHARE ANALYSIS BY IN-VITRO DIAGNOSTICS MAJOR
MAJOR PLAYERS 103
IN-VITRO DIAGNOSTICS MAJOR PLAYERS 109
4 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY TECHNOLOGY 111
4.1 INTRODUCTION 111
4.2 IMMUNOCHEMISTRY 114
4.3 CLINICAL CHEMISTRY 132
4.4 MOLECULAR DIAGNOSTICS 150
4.5 CLINICAL MICROBIOLOGY 167
4.6 HEMATOLOGY 169
4.7 COAGULATION AND HEMOSTASIS 171
4.8 OTHER IVD TECHNOLOGIES 174
5 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY APPLICATION 177
5.1 INTRODUCTION 177
5.2 ONCOLOGY 179
5.3 DIABETES 182
5.4 INFECTIOUS DISEASES 185
5.5 GENETIC TESTING 190
5.6 CARDIOLOGY 192
5.7 AUTOIMMUNE DISEASES 195
5.8 DRUG TESTING 197
5.9 NEPHROLOGY 200
5.10 TRANSPLANTATION TECHNOLOGY 201
5.11 OTHERS 204
6 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY PRODUCT 207
6.1 INTRODUCTION 207
6.2 INSTRUMENTS 209
6.3 REAGENTS 212
6.4 SOFTWARES AND SERVICES 214
7 IN-VITRO DIAGNOSTICS MARKET, BY SAMPLE TYPE 217
7.1 INTRODUCTION 217
7.2 BLOOD 219
7.3 SALIVA 222
7.4 URINE 225
7.5 OTHERS 228
8 IN-VITRO DIAGNOSTICS GLOBAL MARKET, BY END USER 232
8.1 INTRODUCTION 232
8.2 DIAGNOSTIC LABORATORIES 234
8.3 HOSPITALS 236
8.4 ACADEMIC & RESEARCH CENTRES 239
8.5 HOME CARE 241
8.6 OTHER END USERS 243
9 REGIONAL MARKET ANALYSIS 246
9.1 INTRODUCTION 246
9.2 NORTH AMERICA 249
9.3 EUROPE 266
9.4 ASIA PACIFIC 288
9.5 REST OF THE WORLD 311
10 COMPANY DEVELOPMENTS 330
10.1 INTRODUCTION 330
IN-VITRO DIAGNOSTICS MARKET PLAYERS 331
10.2 APPROVAL 331
10.3 NEW PRODUCT LAUNCH 351
10.4 AGREEMENTS PARTERNER SHIPS, COLLABORATIONS &
JOINT VENTURES 362
10.5 MERGERS AND ACQUISITIONS 369
10.6 BUSINESS EXPANSION 372
11 COMPANY PROFILES 373
11.1 ABBOTT LABORATORIES 373
11.2 BECTON DICKINSON AND COMPANY 382
11.3 BIOMERIEUX 394
11.4 BIO-RAD LABORATORIES 407
11.5 CARLYLE GROUP (ORTHO CLINICAL DIAGNOSTICS) 417
11.6 DANAHER CORPORATION 424
11.7 JOHNSON & JOHNSON 442
11.8 ROCHE HOLDINGS AG 450
11.9 SIEMENS AG 468
11.10 SYSMEX CORPORATION (SYSMEX INOSTICS) 481
11.11 THERMOFISHER SCIENTIFIC INC. 491
Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Buy now using our secure payment system.